Literature DB >> 25713080

Histone H2A and H4 N-terminal tails are positioned by the MEP50 WD repeat protein for efficient methylation by the PRMT5 arginine methyltransferase.

Emmanuel S Burgos1, Carola Wilczek1, Takashi Onikubo1, Jeffrey B Bonanno1, Janina Jansong2, Ulf Reimer2, David Shechter3.   

Abstract

The protein arginine methyltransferase PRMT5 is complexed with the WD repeat protein MEP50 (also known as Wdr77 or androgen coactivator p44) in vertebrates in a tetramer of heterodimers. MEP50 is hypothesized to be required for protein substrate recruitment to the catalytic domain of PRMT5. Here we demonstrate that the cross-dimer MEP50 is paired with its cognate PRMT5 molecule to promote histone methylation. We employed qualitative methylation assays and a novel ultrasensitive continuous assay to measure enzyme kinetics. We demonstrate that neither full-length human PRMT5 nor the Xenopus laevis PRMT5 catalytic domain has appreciable protein methyltransferase activity. We show that histones H4 and H3 bind PRMT5-MEP50 more efficiently compared with histone H2A(1-20) and H4(1-20) peptides. Histone binding is mediated through histone fold interactions as determined by competition experiments and by high density histone peptide array interaction studies. Nucleosomes are not a substrate for PRMT5-MEP50, consistent with the primary mode of interaction via the histone fold of H3-H4, obscured by DNA in the nucleosome. Mutation of a conserved arginine (Arg-42) on the MEP50 insertion loop impaired the PRMT5-MEP50 enzymatic efficiency by increasing its histone substrate Km, comparable with that of Caenorhabditis elegans PRMT5. We show that PRMT5-MEP50 prefers unmethylated substrates, consistent with a distributive model for dimethylation and suggesting discrete biological roles for mono- and dimethylarginine-modified proteins. We propose a model in which MEP50 and PRMT5 simultaneously engage the protein substrate, orienting its targeted arginine to the catalytic site.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Enzyme Kinetics; Enzyme Mechanism; Histone Methylation; Peptide Array; Protein Arginine N-methyltransferase 5 (PRMT5); WD Repeat

Mesh:

Substances:

Year:  2015        PMID: 25713080      PMCID: PMC4392268          DOI: 10.1074/jbc.M115.636894

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Negative regulation of transcription by the type II arginine methyltransferase PRMT5.

Authors:  Eric Fabbrizio; Selma El Messaoudi; Jolanta Polanowska; Conception Paul; Jeffry R Cook; Jin-Hyung Lee; Vincent Negre; Mathieu Rousset; Sidney Pestka; Alphonse Le Cam; Claude Sardet
Journal:  EMBO Rep       Date:  2002-07       Impact factor: 8.807

2.  Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes.

Authors:  Sharmistha Pal; Sheethal N Vishwanath; Hediye Erdjument-Bromage; Paul Tempst; Saïd Sif
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

3.  Extraction, purification and analysis of histones.

Authors:  David Shechter; Holger L Dormann; C David Allis; Sandra B Hake
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

4.  Substrate specificity, processivity, and kinetic mechanism of protein arginine methyltransferase 5.

Authors:  Min Wang; Rui-Ming Xu; Paul R Thompson
Journal:  Biochemistry       Date:  2013-08-01       Impact factor: 3.162

5.  A novel WD repeat protein component of the methylosome binds Sm proteins.

Authors:  Westley J Friesen; Anastasia Wyce; Sergey Paushkin; Linda Abel; Juri Rappsilber; Matthias Mann; Gideon Dreyfuss
Journal:  J Biol Chem       Date:  2001-12-26       Impact factor: 5.157

Review 6.  Histone arginine methylation and its dynamic regulation.

Authors:  Joanna Wysocka; C David Allis; Scott Coonrod
Journal:  Front Biosci       Date:  2006-01-01

7.  Histone H4 acetylation differentially modulates arginine methylation by an in Cis mechanism.

Authors:  You Feng; Juxian Wang; Sabrina Asher; Linh Hoang; Carlo Guardiani; Ivaylo Ivanov; Y George Zheng
Journal:  J Biol Chem       Date:  2011-04-18       Impact factor: 5.157

8.  Characterizing DNA methyltransferases with an ultrasensitive luciferase-linked continuous assay.

Authors:  Ivan Hemeon; Jemy A Gutierrez; Meng-Chiao Ho; Vern L Schramm
Journal:  Anal Chem       Date:  2011-05-16       Impact factor: 6.986

9.  PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing.

Authors:  Quan Zhao; Gerhard Rank; Yuen T Tan; Haitao Li; Robert L Moritz; Richard J Simpson; Loretta Cerruti; David J Curtis; Dinshaw J Patel; C David Allis; John M Cunningham; Stephen M Jane
Journal:  Nat Struct Mol Biol       Date:  2009-02-22       Impact factor: 15.369

10.  Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma.

Authors:  Sharmistha Pal; Robert A Baiocchi; John C Byrd; Michael R Grever; Samson T Jacob; Saïd Sif
Journal:  EMBO J       Date:  2007-07-12       Impact factor: 11.598

View more
  34 in total

Review 1.  Chemical biology of protein arginine modifications in epigenetic regulation.

Authors:  Jakob Fuhrmann; Kathleen W Clancy; Paul R Thompson
Journal:  Chem Rev       Date:  2015-05-13       Impact factor: 60.622

2.  A PRMT5-RNF168-SMURF2 Axis Controls H2AX Proteostasis.

Authors:  Changzheng Du; Landon J Hansen; Simranjit X Singh; Feiyifan Wang; Ran Sun; Casey J Moure; Kristen Roso; Paula K Greer; Hai Yan; Yiping He
Journal:  Cell Rep       Date:  2019-09-17       Impact factor: 9.423

3.  PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity.

Authors:  Hyungsoo Kim; Heejung Kim; Yongmei Feng; Yan Li; Hironari Tamiya; Stefania Tocci; Ze'ev A Ronai
Journal:  Sci Transl Med       Date:  2020-07-08       Impact factor: 17.956

4.  PRMT5 is essential for the maintenance of chondrogenic progenitor cells in the limb bud.

Authors:  Jacqueline L Norrie; Qiang Li; Swanie Co; Bau-Lin Huang; Ding Ding; Jann C Uy; Zhicheng Ji; Susan Mackem; Mark T Bedford; Antonella Galli; Hongkai Ji; Steven A Vokes
Journal:  Development       Date:  2016-11-08       Impact factor: 6.868

5.  Histone phosphorylation by TRPM6's cleaved kinase attenuates adjacent arginine methylation to regulate gene expression.

Authors:  Grigory Krapivinsky; Luba Krapivinsky; Nora E Renthal; Ana Santa-Cruz; Yunona Manasian; David E Clapham
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-07       Impact factor: 11.205

6.  SHARPIN-mediated regulation of protein arginine methyltransferase 5 controls melanoma growth.

Authors:  Hironari Tamiya; Hyungsoo Kim; Oleksiy Klymenko; Heejung Kim; Yongmei Feng; Tongwu Zhang; Ji Yun Han; Ayako Murao; Scott J Snipas; Lucia Jilaveanu; Kevin Brown; Harriet Kluger; Hao Zhang; Kazuhiro Iwai; Ze'ev A Ronai
Journal:  J Clin Invest       Date:  2017-12-11       Impact factor: 14.808

7.  Methylosome protein 50 associates with the purinergic receptor P2X5 and is involved in osteoclast maturation.

Authors:  Hyunsoo Kim; Matthew C Walsh; Jiyeon Yu; Paul Laskoski; Kei Takigawa; Noriko Takegahara; Yongwon Choi
Journal:  FEBS Lett       Date:  2019-08-31       Impact factor: 4.124

8.  Biochemical Investigation of the Interaction of pICln, RioK1 and COPR5 with the PRMT5-MEP50 Complex.

Authors:  Adrian Krzyzanowski; Raphael Gasper; Hélène Adihou; Peter 't Hart; Herbert Waldmann
Journal:  Chembiochem       Date:  2021-03-31       Impact factor: 3.164

9.  Germ-line mutations in WDR77 predispose to familial papillary thyroid cancer.

Authors:  Yanyang Zhao; Tian Yu; Jie Sun; Feiliang Wang; Chaoze Cheng; Shurong He; Lan Chen; Donghui Xie; Liping Fu; Xuhuizi Guan; An Yan; Yao Li; Gang Miao; Xiaoquan Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-03       Impact factor: 11.205

10.  Molecular basis for substrate recruitment to the PRMT5 methylosome.

Authors:  Kathleen M Mulvaney; Christa Blomquist; Nischal Acharya; Ruitong Li; Matthew J Ranaghan; Meghan O'Keefe; Diego J Rodriguez; Michael J Young; Devishi Kesar; Debjani Pal; Matthew Stokes; Alissa J Nelson; Sidharth S Jain; Annan Yang; Zachary Mullin-Bernstein; Josie Columbus; Fazli K Bozal; Adam Skepner; Donald Raymond; Salvatore LaRussa; David C McKinney; Yelena Freyzon; Yossef Baidi; Dale Porter; Andrew J Aguirre; Alessandra Ianari; Brian McMillan; William R Sellers
Journal:  Mol Cell       Date:  2021-08-05       Impact factor: 19.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.